By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601



Start Up

Company News
PharmAthene, Inc. (PIP) Reports Third Quarter 2015 Financial And Operational Results 11/9/2015 10:11:35 AM
PharmAthene, Inc. (PIP) Announces Conclusion Of Oral Arguments In Its Litigation Against SIGA 10/8/2015 7:01:54 AM
PharmAthene, Inc. (PIP) Reports Second Quarter 2015 Financial And Operational Results 8/6/2015 8:35:27 AM
Immunovaccine Inc. And PharmAthene, Inc. (PIP) Sign Exclusive Worldwide License Agreement To Develop And Commercialize An Anthrax Vaccine Formulated In DepoVax 7/8/2015 10:52:03 AM
PharmAthene, Inc. (PIP) Reports First Quarter 2015 Financial and Operational Results 5/8/2015 6:52:46 AM
PharmAthene, Inc. (PIP) Receives $5.8 Million Payment From BARDA 4/13/2015 6:57:44 AM
PharmAthene, Inc. (PIP) Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources 3/10/2015 7:48:31 AM
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015 10:28:06 AM
PharmAthene, Inc. (PIP) Awarded $195 Million Plus Post-Judgment Interest By Delaware Court Of Chancery 1/16/2015 9:54:46 AM
Court Orders SIGA Technologies, Inc. (SIGA) to Pay PharmAthene, Inc. (PIP) $113 Million 1/8/2015 6:03:46 AM